Search
for
Sort by
Research 631–660 of 1000+
- Analysis of Chemical Components in Cosmetics and Their Effects on Human Health and Controversies
- Evaluating Testosterone and Dehydroepiandrosterone Sulfate (DHEA-S) as Biomarkers for Male Androgenetic Alopecia
- Investigation Bisphenol A and Phthalate Levels in Idiopathic Hyperandrogenemia
- Subject Index
- Hirsutism
- Diagnosing polycystic ovary syndrome
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Hyperandrogenism in Adolescent Girls
- Female pattern hair loss
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Biology of Hair Growth
- Gender-Affirming Hormone Therapy for Transgender Men
- Prescribing testosterone and DHEA: The role of androgens in women
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Alopecia Possibly Secondary to Topical Ophthalmic β-Blockers
- CLINICAL UPDATES IN HAIR
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Bridging the Gap in PCOD and PCOS Care: A Comprehensive Health & Wellness Platform
- Impact of Chemotherapeutic Drug on People living with Cancer
- POLİKİSTİK OVER SENDROMU FENOTİPLERİ VE METABOLİK DİSFONKSİYON İLİŞKİSİ
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Fertility problems in women with polycystic ovary syndrome
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Variations in anterior segment parameters among different phenotypes of polycystic ovary syndrome
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review